In this June 28, 2011, file photo, bottles of Roundup herbicide, a product of Monsanto, are displayed on a store shelf in St. Louis. German drug and chemicals company Bayer AG announced Monday, May 23, 2016, that it has made a $62 billion offer to buy U.S.-based crops and seeds specialist Monsanto. A Northern California judge has upheld a jury's verdict finding Monsanto's weed killer caused a groundskeeper's cancer, but slashed his $287 million award to $78 million. San Francisco Superior Court Judge Suzanne Bolanos ruled Monday, Oct. 22. (AP Photo/Jeff Roberson, File)
With its stock dropping and more lawsuits expected, Monsanto vowed Tuesday to press on with a nationwide legal defense of its best-selling weed killer Roundup after a San Francisco judge upheld a verdict alleging it causes cancer.
Legal experts said the decision will have little value in courtrooms across the country where similar cases are pending, but it will likely lead to more lawsuits. Similar lawsuits doubled from 4,000 to 8,000 after a San Francisco jury awarded groundskeeper DeWayne Johnson $389 million in August.
Monsanto's lawyers said they will fight Johnson and every other lawsuit in the country alleging that the active ingredient in the world's most popular herbicide—glyphosate—causes cancer. Johnson's lawsuit was the first lawsuit to go to trial, and several more appear ready to start early next year.
Judge Suzanne Bolanos cut the jury's award for Johnson to $78 million on Monday but upheld its verdict against St. Louis-based Monsanto.
She reduced punitive damages from $250 million to $39 million in a brief decision that stood in sharp contrast to an earlier tentative ruling saying she doubted Johnson should receive any such award.
Bolanos previously said Johnson's attorneys failed to show Monsanto executives acted with malice, which is required for punitive damages. She didn't explain her change of mind. Several jurors wrote to the judge asking her to respect their verdict, but legal experts said that should not have influenced the judge.
This Aug. 31, 2015 file photo shows the Monsanto logo on display at the Farm Progress Show in Decatur, Ill. After a Northern California judge upheld a jury's verdict that found Monsanto's weed killer caused a groundskeeper's cancer, hundreds of other plaintiffs are wondering what the case might mean for their outstanding claims lawsuits against the agribusiness giant. (AP Photo/Seth Perlman, File)
Monsanto's lawyer said it would appeal the decision if Johnson accepts the award rather than asking for a new trial. He has until Dec. 7 to decide.
Monsanto argues that numerous scientific studies and the U.S. Environmental Protection Agency have found glyphosate to be safe.
"Because of this, we will continue to vigorously defend our glyphosate-based products," company spokesman Daniel Childs said.
Johnson's attorney argued that the World Health Organization in 2015 concluded otherwise.
Legal experts say the San Francisco decision will have no immediate legal effect on the other lawsuits, especially since they predict months—if not years—of appeals.
In this Aug. 10, 2018, file photo, plaintiff DeWayne Johnson reacts after hearing the verdict in his case against Monsanto at the Superior Court in San Francisco. A Northern California judge has upheld a jury's verdict finding Monsanto's weed killer caused the groundskeeper's cancer, but slashed his $287 million award to $78 million. San Francisco Superior Court Judge Suzanne Bolanos ruled Monday, Oct. 22. (Josh Edelson/Pool Photo via AP, File)
A San Francisco trial court decision also is not binding in any other court. California appeals court decisions are binding in California courts but not on state court actions elsewhere.
"It's just one early piece in a large, legal puzzle," said University of California, Hastings law professor David Levine.
Levine said the company will not consider settling any lawsuit until enough trial court decisions pile up against it. "There just aren't enough data points to make a decision," he said.
The German company Bayer Ag bought St. Louis-based Monsanto in August for $63 billion. Its stock price fell 8.6 percent per share Tuesday.
"Clearly this topic isn't going to go away," UBS analyst Michael Leuchten wrote in a note to investors Tuesday.
© 2018 The Associated Press. All rights reserved.
